Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Depth camera could guide oxygen therapy and prevent intubation in respiratory failure

NCT ID NCT06819644

Disease control Sponsor: University Hospital, Brest Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time

Summary

This phase 3 trial tests whether adjusting the flow rate of high-flow oxygen therapy based on lung volume measurements from a depth camera can reduce the need for intubation in intensive care patients with hypoxemic respiratory failure. About 406 participants will be randomly assigned to either standard high-flow oxygen or a strategy where the flow rate is tailored using the camera's lung volume readings. The main goal is to see if this personalized approach lowers the rate of intubation within 28 days.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
high-flow oxygen therapy with flow rate adjustment guided by depth camera lung volume measurements
What this could lead to
If successful, this approach could reduce the need for intubation and mechanical ventilation in intensive care patients with breathing failure.
What could go wrong
This is a single trial testing a new technique; results may not apply to all patients, and the depth camera method may not improve outcomes over standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 406 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

Oct 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with hypoxemic respiratory distress define by the following 4 criteria: * Respiratory rate ≥ 25 breaths per minutes * A ratio of the partial pressure of arterial oxygen (PaO2) to the FiO2 ≤ 300 mmHg while the patient is breathing oxygen at a flow rate of 10 liters per minutes or more * A partial pressure of arterial carbon dioxide (PaCO2) not higher than 45 mmHg * An absence of clinical history of underlying chronic respiratory failure Exclusion Criteria: * A do-not-intubate order * Pregnant or lactating woman * Cardiogenic pulmonary edema * Exacerbation of asthma * Hemodynamic instability with use of vasopressor at significant dose (norepinephrine \> 0.5 mg/h) * A Glasgow Coma Scale of 12 points of less * Contraindications to non-invasive ventilation * Urgent need for endotracheal intubation * High flow oxygen therapy started within 48 hours before inclusion * Patient under legal protection or deprived of liberty

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hypoxemic respiratory failure are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

respiratory failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hypoxemic respiratory failure

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    8 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • AP-HP - Hôpital Henri Mondor

    NOT_YET_RECRUITING

    Créteil, 94010, France

  • AP-HP - Hôpital Louis Mourier

    NOT_YET_RECRUITING

    Colombes, 92700, France

  • Brest, University Hospital

    RECRUITING

    Brest, France

  • CH Morlaix

    NOT_YET_RECRUITING

    Morlaix, 29672, France

  • CH Poitiers

    NOT_YET_RECRUITING

    Poitiers, 86000, France

  • CHR Orléans

    NOT_YET_RECRUITING

    Orléans, 45067, France

  • CHU Rennes

    NOT_YET_RECRUITING

    Rennes, 35033, France

  • CHU Tours

    NOT_YET_RECRUITING

    Tours, 37044, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.